Dale O Kiesewetter Selected Research

Dale O Kiesewetter Research Topics

Disease

62	Neoplasms (Cancer) 01/2019 - 01/2003
10	Insulinoma 01/2019 - 10/2011
9	Neoplasm Metastasis (Metastasis) 04/2016 - 02/2009
5	Breast Neoplasms (Breast Cancer) 06/2012 - 09/2008
4	Inflammation (Inflammations) 10/2014 - 04/2011
3	Prostatic Neoplasms (Prostate Cancer) 01/2018 - 10/2012
2	Pain (Aches) 09/2018 - 04/2011
2	Carcinoma (Carcinomatosis) 04/2016 - 11/2015
2	Stroke (Strokes) 10/2014 - 01/2002
2	Neuroinflammatory Diseases 10/2014 - 07/2014
2	Glioblastoma (Glioblastoma Multiforme) 08/2014 - 02/2014
2	Myocardial Infarction 07/2014 - 04/2012
2	Pheochromocytoma 02/2012 - 02/2011
2	Alzheimer Disease (Alzheimer's Disease) 11/2003 - 09/2003
1	Hyperthermia 01/2019
1	Colorectal Neoplasms (Colorectal Cancer) 01/2019
1	Starvation 01/2019
1	Painful Neuropathy 09/2018
1	Neuralgia (Stump Neuralgia) 09/2018
1	Anhedonia 09/2018
1	Chronic Pain 09/2018
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2018
1	Hepatocellular Carcinoma (Hepatoma) 11/2017

Drug/Important Bio-Agent (IBA)

13	Peptides (Polypeptides)IBA 01/2019 - 11/2010
9	IntegrinsIBA 01/2017 - 03/2011
9	1,4,7- triazacyclononane- N,N',N''- triacetic acid (NOTA)IBA 01/2017 - 12/2011
6	Exenatide (Byetta)FDA Link 01/2019 - 01/2012
6	Pharmaceutical PreparationsIBA 01/2019 - 11/2005
6	Chemokine ReceptorsIBA 02/2016 - 02/2009
6	Proteins (Proteins, Gene)FDA Link 02/2016 - 01/2012
5	Glucagon-Like Peptide-1 ReceptorIBA 01/2019 - 01/2012
5	AlbuminsIBA 01/2018 - 07/2014
4	Evans Blue (Blue, Evans)FDA Link 01/2018 - 01/2016
4	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2017 - 12/2012
4	arginyl-glycyl-aspartic acidIBA 08/2014 - 09/2012
4	LigandsIBA 07/2014 - 11/2010
3	AntigensIBA 01/2019 - 01/2018
3	ProdrugsIBA 01/2019 - 01/2018
3	Paclitaxel (Taxol)FDA LinkGeneric 01/2018 - 11/2005
3	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 01/2018 - 01/2012
3	Radioisotopes (Radionuclides)IBA 01/2018 - 01/2018
3	GoldIBA 01/2017 - 08/2014
3	68Ga-NOTA-exendin-4IBA 05/2016 - 03/2015
3	Sulfhydryl Compounds (Thiols)IBA 10/2015 - 07/2013
3	cyclic arginine-glycine-aspartic acid peptideIBA 09/2012 - 03/2011
3	Glucagon-Like Peptide 1 (GLP 1)IBA 03/2012 - 10/2011
3	Epidermal Growth Factor (EGF)IBA 02/2012 - 05/2008
2	2-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a (HPPH)IBA 01/2019 - 01/2014
2	RadiopharmaceuticalsIBA 01/2018 - 01/2003
2	Monoclonal AntibodiesIBA 11/2017 - 09/2008
2	Small Interfering RNA (siRNA)IBA 01/2017 - 01/2012
2	zinc(II) dipicolylamineIBA 01/2017 - 01/2012
2	Matrix Metalloproteinases (MMPs)IBA 11/2014 - 02/2014
2	N,N- diethyl- 2- (2- (4- (2- fluoroethoxy)phenyl)- 5,7- dimethylpyrazolo(1,5- a)pyrimidin- 3- yl)acetamideIBA 10/2014 - 07/2014
2	plerixafor FDA Link 10/2014 - 02/2012
2	Chelating AgentsIBA 08/2014 - 12/2011
2	TurpentineIBA 07/2014 - 01/2014
2	alfatide IIIBA 01/2014 - 04/2012
2	ErbB Receptors (EGF Receptor)IBA 02/2012 - 07/2009
2	Norepinephrine Plasma Membrane Transport Proteins (Norepinephrine Transporter)IBA 02/2012 - 02/2011
2	FP-TZTPIBA 07/2006 - 11/2003
2	Cholinergic Agents (Cholinergics)IBA 07/2006 - 09/2003
2	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 11/2005 - 08/2003
1	BilirubinIBA 01/2019
1	Glucose (Dextrose)FDA LinkGeneric 01/2019
1	Oxygen (Dioxygen)IBA 01/2019
1	VaccinesIBA 01/2019
1	Tirapazamine (SR 4233)IBA 01/2019
1	Glucose OxidaseIBA 01/2019
1	AminesIBA 01/2019
1	Opioid Analgesics (Opioids)IBA 09/2018
1	Opioid Receptors (Opioid Receptor)IBA 09/2018
1	salicylhydroxamic acid (SHAM)IBA 09/2018
1	Sucrose (Saccharose)IBA 09/2018
1	PSMA-617IBA 01/2018
1	177Lu-EB-PSMA-617IBA 01/2018
1	peptide AIBA 01/2018
1	AcidsIBA 01/2018
1	Folic Acid (Vitamin M)FDA LinkGeneric 01/2018
1	Serum AlbuminIBA 01/2018
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2018
1	Somatostatin Receptors (Somatostatin Receptor)IBA 01/2018
1	Therapeutic UsesIBA 01/2018
1	EphA2 ReceptorIBA 11/2017
1	Immunoconjugates (Immunoconjugate)IBA 11/2017
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 11/2017
1	Erythropoietin FDA Link 11/2017
1	Coloring Agents (Dyes)IBA 01/2017
1	Bevacizumab (Avastin)FDA Link 01/2017
1	AS 8IBA 01/2017

Therapy/Procedure

19	Therapeutics 01/2019 - 05/2008
5	Drug Therapy (Chemotherapy) 01/2019 - 11/2005
4	Intravenous Injections 01/2019 - 10/2011
4	Aftercare (After-Treatment) 01/2017 - 02/2011
3	Radiotherapy 01/2019 - 01/2017
3	Precision Medicine 01/2017 - 02/2014
2	Photothermal Therapy 01/2017 - 08/2014
2	Photochemotherapy (Photodynamic Therapy) 01/2016 - 01/2014
1	Immunotherapy 01/2019
1	Lasers (Laser) 01/2019